Information on the Target
De Novo Foodlabs, an innovative food technology company, has introduced NanoFerrin™, a groundbreaking animal-free lactoferrin protein that stands to transform the lactoferrin market. With a commitment to sustainable practices, De Novo aims to provide high-quality nutritional ingredients that address both consumer health and environmental concerns.
As the flagship product of De Novo Foodlabs, NanoFerrin™ is produced through precision fermentation, dramatically reducing the environmental impact associated with traditional lactoferrin production methods. This revolutionary product boasts a significant reduction of 98% in greenhouse gas emissions and requires 99% less land and water than conventional bovine-derived lactoferrin.
Industry Overview in the Target’s Specific Country
The global lactoferrin market has experienced remarkable growth, valued at $773 million in 2023, with future projections indicating an annual growth rate of 15.8%. Lactoferrin, often referred to as
Similar Deals
Hyde Park Angels → The Eastman Egg Company
2023
Joyful Ventures
invested in
De Novo Foodlabs
in 2023
in a Series A deal
Disclosed details
Transaction Size: $4M